19-13312714-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_ModerateBP6BP7BS1BS2

The NM_023035.3(CACNA1A):​c.1626G>A​(p.Gly542Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000999 in 1,598,026 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G542G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0012 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00098 ( 7 hom. )

Consequence

CACNA1A
NM_023035.3 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6

Conservation

PhyloP100: 0.392

Publications

1 publications found
Variant links:
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
CACNA1A Gene-Disease associations (from GenCC):
  • episodic ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
  • developmental and epileptic encephalopathy, 42
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • migraine, familial hemiplegic, 1
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 6
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • benign paroxysmal torticollis of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.3).
BP6
Variant 19-13312714-C-T is Benign according to our data. Variant chr19-13312714-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 93560.
BP7
Synonymous conserved (PhyloP=0.392 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00122 (186/152266) while in subpopulation NFE AF = 0.00198 (135/68026). AF 95% confidence interval is 0.00171. There are 1 homozygotes in GnomAd4. There are 93 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 186 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_023035.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1A
NM_001127222.2
MANE Select
c.1623G>Ap.Gly541Gly
synonymous
Exon 12 of 47NP_001120694.1
CACNA1A
NM_001127221.2
MANE Plus Clinical
c.1626G>Ap.Gly542Gly
synonymous
Exon 12 of 47NP_001120693.1
CACNA1A
NM_023035.3
c.1626G>Ap.Gly542Gly
synonymous
Exon 12 of 48NP_075461.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1A
ENST00000360228.11
TSL:1 MANE Select
c.1623G>Ap.Gly541Gly
synonymous
Exon 12 of 47ENSP00000353362.5
CACNA1A
ENST00000638009.2
TSL:1 MANE Plus Clinical
c.1626G>Ap.Gly542Gly
synonymous
Exon 12 of 47ENSP00000489913.1
CACNA1A
ENST00000638029.1
TSL:5
c.1626G>Ap.Gly542Gly
synonymous
Exon 12 of 48ENSP00000489829.1

Frequencies

GnomAD3 genomes
AF:
0.00122
AC:
186
AN:
152148
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00387
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00198
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00128
AC:
302
AN:
235208
AF XY:
0.00130
show subpopulations
Gnomad AFR exome
AF:
0.0000698
Gnomad AMR exome
AF:
0.000162
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00435
Gnomad NFE exome
AF:
0.00177
Gnomad OTH exome
AF:
0.00197
GnomAD4 exome
AF:
0.000975
AC:
1410
AN:
1445760
Hom.:
7
Cov.:
29
AF XY:
0.000992
AC XY:
713
AN XY:
718922
show subpopulations
African (AFR)
AF:
0.0000932
AC:
3
AN:
32198
American (AMR)
AF:
0.000167
AC:
7
AN:
41922
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25864
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38384
South Asian (SAS)
AF:
0.0000121
AC:
1
AN:
82936
European-Finnish (FIN)
AF:
0.00546
AC:
291
AN:
53260
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5736
European-Non Finnish (NFE)
AF:
0.000945
AC:
1045
AN:
1105670
Other (OTH)
AF:
0.00105
AC:
63
AN:
59790
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
72
143
215
286
358
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00122
AC:
186
AN:
152266
Hom.:
1
Cov.:
32
AF XY:
0.00125
AC XY:
93
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41542
American (AMR)
AF:
0.000131
AC:
2
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00387
AC:
41
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00198
AC:
135
AN:
68026
Other (OTH)
AF:
0.00142
AC:
3
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
9
17
26
34
43
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00162
Hom.:
2
Bravo
AF:
0.000623
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
not provided (3)
-
-
1
CACNA1A-related disorder (1)
-
-
1
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.30
CADD
Benign
9.2
DANN
Benign
0.69
PhyloP100
0.39
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375628894; hg19: chr19-13423528; API